Physician profile
Anna Kiryn Trask
NPI 1790035681
$4,155.46
in general payments reported to CMS, 2019-2025
12 companies · $265 in 2025
The $265 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $14.79 · 2022: $2,035 · 2023: $413 · 2024: $1,429 · 2025: $265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,505 · Travel and Lodging: $601.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,505.29 |
| Travel and Lodging | $600.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,519.68 | 2022-2024 | |
| Gemini Mountain Medical, LLC | $1,443.18 | 2022-2024 | |
| Ossur Americas, INC. | $586.22 | 2024-2025 | Miami J, Unloader One X |
| Medical Device Business Services, INC. | $212.14 | 2023-2025 | Stratafix, Healix Knotless Peek |
| Davol INC. | $159.88 | 2023 | Arista Ah Flexitip |
| Stryker Corporation | $60.95 | 2024 | Crossflow |
| Horizon Therapeutics Plc | $39.70 | 2022 | |
| Smith+Nephew, INC. | $39.69 | 2021-2025 | Aetos Shoulder System |
| Vericel Corporation | $39.39 | 2022-2023 | Maci |
| Bioventus LLC | $24.40 | 2024 | Exogen Ultrasound Bone Healing System |
| Ferring Pharmaceuticals INC. | $15.35 | 2023 | Euflexxa |
| Anika Therapeutics, INC. | $14.88 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Trask listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.